Global Heart Failure Drugs Market Analysis, Trends And Opportunities 2020-2025
Summary -
A new market
study, titled “Global Heart Failure Drugs Products Market - Global Demand, Sales,
Consumption and Forecasts to 2020-2025 “ has been featured on WiseGuyReports.
Global Heart Failure Drugs Market
Research Report—Forecast till 2025
Market
Overview
The Global
Heart Failure Drugs Market is expected to register a CAGR of 17.79% to reach
USD 13,069.75 Million during the review period. Heart failure is considered a
chronic disease it causes because of the improper working of heart muscles. In
this disease, the heart muscle is unable to pump a sufficient amount of blood
to the body’s requirement due to which patient causes fatigue and shortness of
breath and sometimes results in a cough.
The
increasing prevalence of cardiovascular disorders, rising geriatric population,
and the adoption of changing lifestyle habits like unhealthy dietary habits,
excessive alcohol consumption, smoking, obesity, and lack of physical activity
attribute the growth of the global market. However, a strong pipeline and
product approvals are also propelling market growth. Furthermore, the serious
side-effects of such drugs can hinder the growth of the global market.
Market
Segmentation
The Global
Heart Failure Drugs Market has been classified based on, and end-user. The
market, by type, has been further segmented into Beta-Blockers, ACE Inhibitors,
Angiotensin-Receptor Neprilysin Inhibitors (ARNI), Angiotensin Receptor
Blockers (ARBs), Diuretic, and others. The global heart failure drugs market,
by end-user, has been categorized as hospitals, specialty centers, and others.
Regional
Analysis
The
geographical analysis of global reference check software market spans across
North America, Europe, Asia-Pacific, the Middle East, and Africa.
In 2018 the
Americas were the largest market for heart failure drugs and it is expected to
command the market during the forecast period. The regional market growth is
driven by the increasing rate of cardiovascular disorders, increasing
healthcare expenditure, and growing obesity cases. Furthermore, the adoption of
modern lifestyle habits such as unhealthy dietary habits, regular alcohol
consumption, smoking, obesity, and lack of physical workouts are making
individuals more susceptible to arrhythmia and heart failure and are driving
the market growth.
Europe is
anticipated as the second-largest market for heart failure owing to increasing
cardiovascular disorders and rising cigarette smoking population. Western
Europe, is dominating the regional market.
Asia-Pacific
is evaluated to exhibit the fastest-growing market during the review period
owing to the increasing patient pool and rising technological advancements.
Furthermore the rising per capita expenditure along with government initiatives
to enhance the quality of healthcare and rising cardiovascular diseases being
the major concern in this region and attributes to the market growth. The
Middle East & Africa exhibits the limited growth in the evaluation period,
the regional market of heart failure drugs is propelled by increasing obesity
issues, rising initiatives by governments to improve patient care, and
favorable reimbursement policies.
Major
Players
The key
players in the global heart failure drugs market are Amgen Inc. (US),
AstraZeneca (UK), Novartis AG (Switzerland), Boehringer Ingelheim International
GmbH (Germany), Johnson & Johnson Services, Inc. (UK), Bristol-Myers Squibb
Company (US), Merck Sharp & Dohme Corp. (US), Pfizer, Inc. (US), Gilead
Sciences, Inc. (California), and others.
We are
continuously tracking the impact of COVID-19 pandemic on various industries and
verticals within all domains. Our research reports include the same and help
you understand the drop and rise, owing to the impact of COVID-19 on the
industries. Also, we help you to identify the gap between the demand and supply
of your interested market. Moreover, the report helps you with the analysis,
amended government regulations and many other useful insights...
FOR MORE DETAILS:- https://www.wiseguyreports.com/reports/5415382-global-heart-failure-drugs-market-research-report-forecast-till-2025
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH
TRENT
Ph: +162-825-80070
(US)
Ph: +44 2035002763
(UK)
Comments
Post a Comment